| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |